Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Víctor Albarrán

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Diagnostics (Basel, Switzerland)|September 23, 2022
Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with ImmunotherapyVíctor Albarrán-Artahona, Juan-Carlos Laguna, Teresa Gorría, et al.
Frontiers in Pharmacology|March 3, 2022
Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of LiteratureVíctor Albarrán, Jesús Chamorro, Diana Isabel Rosero, et al.
Case Reports in Oncological Medicine|July 26, 2021
Management of Intracranial Metastases in EGFR-Mutated NSCLC: A Review of Literature following an Unusual Case ReportVíctor Albarrán, Javier Pozas, Juan José Soto, et al.
Journal for Immunotherapy of Cancer|March 14, 2024
Biomarkers for response to TIL therapy: a comprehensive reviewVíctor Albarrán Fernández, Pablo Ballestín Martínez, Joachim Stoltenborg Granhøj, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2023
Biomarkers of response to immunotherapy in early stage non-small cell lung cancerMatthieu Roulleaux Dugage, Víctor Albarrán-Artahona, Juan Carlos Laguna, et al.
Translational Lung Cancer Research|August 25, 2021
Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: a case report and review of literatureVíctor Albarrán, Javier Pozas, Fernando Rodríguez, et al.
Cancers|December 23, 2022
Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?Javier Pozas, Sara Álvarez Rodríguez, Víctor Albarrán Fernández, et al.
International Journal of Molecular Sciences|January 16, 2021
Novel Tyrosine Kinase Targets in Urothelial CarcinomaJavier Torres-Jiménez, Víctor Albarrán-Fernández, Javier Pozas, et al.
Diagnostic Pathology|August 30, 2018
Pleomorphic lobular carcinoma of the breast with osteoclast-like giant cells: a case report and review of the literatureLourdes Peña-Jaimes, Irene González-García, María Eugenia Reguero-Callejas, et al.
International Journal of Radiation Oncology, Biology, Physics|March 16, 2026
Tumor purity as a prognostic and predictive biomarker of postoperative radiotherapy outcomes in stage IIIA-N2 non-small-cell lung cancer: a transcriptomic analysis from the Lung ART trialWael S Zrafi, Víctor Albarrán-Artahona, Filippo G Dall'Olio, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Diagnostics (Basel, Switzerland)|September 23, 2022
Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with ImmunotherapyVíctor Albarrán-Artahona, Juan-Carlos Laguna, Teresa Gorría, et al.
Frontiers in Pharmacology|March 3, 2022
Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of LiteratureVíctor Albarrán, Jesús Chamorro, Diana Isabel Rosero, et al.
Case Reports in Oncological Medicine|July 26, 2021
Management of Intracranial Metastases in EGFR-Mutated NSCLC: A Review of Literature following an Unusual Case ReportVíctor Albarrán, Javier Pozas, Juan José Soto, et al.
Journal for Immunotherapy of Cancer|March 14, 2024
Biomarkers for response to TIL therapy: a comprehensive reviewVíctor Albarrán Fernández, Pablo Ballestín Martínez, Joachim Stoltenborg Granhøj, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2023
Biomarkers of response to immunotherapy in early stage non-small cell lung cancerMatthieu Roulleaux Dugage, Víctor Albarrán-Artahona, Juan Carlos Laguna, et al.
Translational Lung Cancer Research|August 25, 2021
Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: a case report and review of literatureVíctor Albarrán, Javier Pozas, Fernando Rodríguez, et al.
Cancers|December 23, 2022
Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?Javier Pozas, Sara Álvarez Rodríguez, Víctor Albarrán Fernández, et al.
International Journal of Molecular Sciences|January 16, 2021
Novel Tyrosine Kinase Targets in Urothelial CarcinomaJavier Torres-Jiménez, Víctor Albarrán-Fernández, Javier Pozas, et al.
Diagnostic Pathology|August 30, 2018
Pleomorphic lobular carcinoma of the breast with osteoclast-like giant cells: a case report and review of the literatureLourdes Peña-Jaimes, Irene González-García, María Eugenia Reguero-Callejas, et al.
International Journal of Radiation Oncology, Biology, Physics|March 16, 2026
Tumor purity as a prognostic and predictive biomarker of postoperative radiotherapy outcomes in stage IIIA-N2 non-small-cell lung cancer: a transcriptomic analysis from the Lung ART trialWael S Zrafi, Víctor Albarrán-Artahona, Filippo G Dall'Olio, et al.
Pageof 3